On April 3, 2020, Hikma Pharmaceuticals PLC, a division of the Hikma Group, announced the launch of its neuromuscular blocking agent, Vacuronium Bromide. The multinational company for generic pharmaceuticals launched this drug in the form of injection in the United States.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?